Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.334473670945834e-45,298.56880733944956,30850.455689514743,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.603078911553752e-43,0,0,64
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.3763796275063367e-29,98.08333333333333,6518.178047380469,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A6']",1.8581124971335546e-27,0,0,44
3,Nonalcoholic fatty liver disease WP4396,5.999278306630222e-21,21.43519522776573,998.0794453382973,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",5.3993504759672e-19,0,0,39
4,Oxidative phosphorylation WP623,2.66592915599968e-13,31.174337517433752,902.5922638604316,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFB2', 'ATP5MC3', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",1.799502180299784e-11,0,0,22
5,Mitochondrial complex I assembly model OXPHOS system WP4324,2.0250248461174523e-11,37.96058091286307,934.6978435755527,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAF3']",1.0935134169034242e-09,0,0,18
6,Mitochondrial CIV Assembly WP4922,2.9404364445601874e-10,62.90721649484536,1380.6431065070835,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",1.3231964000520843e-08,0,0,15
7,Mitochondrial complex III assembly WP4921,2.1890708811024076e-06,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",8.443559112823572e-05,0,0,8
8,Cholesterol Biosynthesis Pathway WP197,0.0003349287196182032,24.704453441295545,197.6749774270749,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'FDFT1']",0.010047861588546095,0,0,6
9,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.0003349287196182032,24.704453441295545,197.6749774270749,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'FDFT1']",0.010047861588546095,0,0,6
10,Selenium Micronutrient Network WP15,0.0004693044819907813,5.063849125198819,38.8106501428838,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'SELENOK', 'SEPHS2', 'LDLR', 'SELENOH', 'SOD1', 'MSRB1']",0.012671221013751096,0,0,11
11,Eukaryotic Transcription Initiation WP405,0.00147505143704181,20.545454545454547,133.93710057213212,"['TAF13', 'TAF7', 'POLR2I', 'POLR3K', 'POLR2K']",0.036205808000117155,0,0,5
12,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.0027925741944356307,8.226720647773279,48.37962851437084,"['IDI1', 'SQLE', 'HMGCS1', 'HMGCR', 'LDLR', 'FDFT1']",0.06283291937480169,0,0,6
13,Statin inhibition of cholesterol production WP430,0.006319460368193901,16.403225806451612,83.06792780734719,"['SQLE', 'HMGCR', 'LDLR', 'FDFT1']",0.1312503307240272,0,0,4
14,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.007636163303694532,inf,inf,"['HMGCS1', 'HMGCR', 'LDLR']",0.13745093946650158,0,0,3
15,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.007636163303694532,inf,inf,"['IDI1', 'HMGCS1', 'HMGCR']",0.13745093946650158,0,0,3
16,mRNA Processing WP411,0.00967388129887151,6.841750841750842,31.734268589708744,"['SF3B5', 'LSM7', 'SNRPE', 'SNU13', 'SRSF9']",0.15572874603031142,0,0,5
17,Pyrimidine metabolism WP4022,0.009805143268575163,3.6603432700993674,16.928532012114545,"['POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.15572874603031142,0,0,8
18,Nanomaterial induced apoptosis WP2507,0.016008312110381652,8.19758064516129,33.894103736199284,"['ENDOG', 'BAX', 'CYCS', 'FADD']",0.23401587613840283,0,0,4
19,Androgen receptor signaling pathway WP138,0.016467783876406124,3.5976166328600407,14.7730705384607,"['KAT5', 'PRDX1', 'BAG1', 'STUB1', 'PARK7', 'CALR', 'FKBP4']",0.23401587613840283,0,0,7
20,Histone Modifications WP2369,0.02604810662241594,12.277665995975855,44.786595201547016,"['SET', 'H3F3B', 'H3F3A']",0.34112445461591256,0,0,3
21,Integrated breast cancer pathway WP1984,0.029223877532110254,2.741192411924119,9.684000069732258,"['GADD45A', 'TRADD', 'ODC1', 'BAX', 'PHB', 'FADD', 'HMGCR', 'FAU']",0.34112445461591256,0,0,8
22,Synaptic Vesicle Pathway WP2267,0.030724461675659853,4.101010101010101,14.28257206697692,"['SLC32A1', 'PARK7', 'AP2M1', 'VAMP2', 'CPLX3']",0.34112445461591256,0,0,5
23,Proteasome Degradation WP183,0.030724461675659853,4.101010101010101,14.28257206697692,"['PSMD8', 'PSMB6', 'H2AFZ', 'HLA-B', 'PSMB10']",0.34112445461591256,0,0,5
24,Copper homeostasis WP3286,0.03158559764962153,5.462365591397849,18.872768265546785,"['SCO2', 'COX17', 'ATOX1', 'SOD1']",0.34112445461591256,0,0,4
25,Folate Metabolism WP176,0.03158559764962153,5.462365591397849,18.872768265546785,"['AHCY', 'GPX4', 'LDLR', 'SOD1']",0.34112445461591256,0,0,4
26,7q11.23 copy number variation syndrome WP4932,0.034641768162605294,2.8752535496957403,9.668601174159832,"['ATP5F1B', 'EIF4H', 'ATP5MC3', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.34956367791341747,0,0,7
27,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.03884040865704638,inf,inf,"['COX8A', 'GSTP1']",0.34956367791341747,0,0,2
28,Cellular Proteostasis WP4918,0.03884040865704638,inf,inf,"['VBP1', 'PFDN6']",0.34956367791341747,0,0,2
29,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.03884040865704638,inf,inf,"['H3F3B', 'H3F3A']",0.34956367791341747,0,0,2
30,SARS-CoV-2 mitochondrial interactions WP5038,0.03884040865704638,inf,inf,"['NDUFB9', 'PHB']",0.34956367791341747,0,0,2
31,Cytosolic DNA-sensing pathway WP4655,0.04740521715719238,3.4158249158249157,10.41492869724461,"['TRADD', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.412884149433611,0,0,5
32,Genotoxicity pathway WP4286,0.053497345942944544,4.094758064516129,11.989956229814707,"['RPS27', 'GADD45A', 'TRIAP1', 'PHLDA3']",0.41730847417268674,0,0,4
33,VEGFA-VEGFR2 Signaling Pathway WP3888,0.05439382764884791,1.6351784476784477,4.760829562253785,"['SET', 'SSR4', 'TRPC3', 'RPL13A', 'RPL10A', 'RPL7', 'DNAJA1', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'SH3BGRL3', 'RPL26', 'FADD', 'CALR', 'CCT7', 'HRAS']",0.41730847417268674,0,0,19
34,Vitamin B12 metabolism WP1533,0.05564112988969157,6.135814889336016,17.72534211046937,"['CUBN', 'LDLR', 'SOD1']",0.41730847417268674,0,0,3
35,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.05564112988969157,6.135814889336016,17.72534211046937,"['H3F3B', 'H2AFZ', 'H3F3A']",0.41730847417268674,0,0,3
36,p38 MAPK Signaling Pathway WP400,0.05564112988969157,6.135814889336016,17.72534211046937,"['TRADD', 'DDIT3', 'HRAS']",0.41730847417268674,0,0,3
37,Apoptosis Modulation and Signaling WP1772,0.06847710300273674,2.9264069264069263,7.846445697715819,"['ENDOG', 'TRADD', 'CYCS', 'BAX', 'FADD']",0.4996977786686195,0,0,5
38,Apoptosis WP254,0.08167482022160545,3.274193548387097,8.201886017679128,"['TRADD', 'CYCS', 'BAX', 'FADD']",0.5579025186567595,0,0,4
39,Glycolysis in senescence WP5049,0.09527398792545154,4.0885311871227366,9.612130503920449,"['LDHA', 'PKM', 'ALDOC']",0.5579025186567595,0,0,3
40,Parkinson's disease pathway WP2371,0.09527398792545154,4.0885311871227366,9.612130503920449,"['PINK1', 'CYCS', 'PARK7']",0.5579025186567595,0,0,3
41,Photodynamic therapy-induced unfolded protein response WP3613,0.09527398792545154,4.0885311871227366,9.612130503920449,"['XBP1', 'DDIT3', 'CALR']",0.5579025186567595,0,0,3
42,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.09527398792545154,4.0885311871227366,9.612130503920449,"['CXCL12', 'TRADD', 'FADD']",0.5579025186567595,0,0,3
43,Ciliary landscape WP4352,0.09943017323541076,2.2348178137651824,5.158629194550648,"['PSMD8', 'EXOSC4', 'H3F3A', 'COPS7A', 'COX6C', 'LSM4']",0.5579025186567595,0,0,6
44,Amyotrophic lateral sclerosis (ALS) WP2447,0.10124897560807858,8.168674698795181,18.707675712740627,"['BAX', 'SOD1']",0.5579025186567595,0,0,2
45,TP53 network WP1742,0.10124897560807858,8.168674698795181,18.707675712740627,"['GADD45A', 'BAX']",0.5579025186567595,0,0,2
46,Vitamin D-sensitive calcium signaling in depression WP4698,0.10124897560807858,8.168674698795181,18.707675712740627,"['CALB1', 'GPX4']",0.5579025186567595,0,0,2
47,EV release from cardiac cells and their functional effects WP3297,0.10124897560807858,8.168674698795181,18.707675712740627,"['CXCL12', 'RGS16']",0.5579025186567595,0,0,2
48,Mevalonate pathway WP3963,0.10124897560807858,8.168674698795181,18.707675712740627,"['HMGCS1', 'HMGCR']",0.5579025186567595,0,0,2
49,Nanoparticle triggered regulated necrosis WP2513,0.10124897560807858,8.168674698795181,18.707675712740627,"['TRADD', 'FADD']",0.5579025186567595,0,0,2
50,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.14304030694722003,3.0648893360160967,5.9600721380625625,"['PPP1R14B', 'XBP1', 'DDIT3']",0.6757264526890975,0,0,3
51,Leptin signaling pathway WP2034,0.14304030694722003,3.0648893360160967,5.9600721380625625,"['CFL2', 'BAX', 'HRAS']",0.6757264526890975,0,0,3
52,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.14304030694722003,3.0648893360160967,5.9600721380625625,"['CXCL12', 'TRADD', 'FADD']",0.6757264526890975,0,0,3
53,TNF-alpha signaling pathway WP231,0.15463406520469655,2.3364055299539173,4.361353770687086,"['TRADD', 'BAX', 'FADD', 'HRAS']",0.6757264526890975,0,0,4
54,Translation Factors WP107,0.15463406520469655,2.3364055299539173,4.361353770687086,"['EEF1B2', 'EEF1G', 'EIF3I', 'EIF4H']",0.6757264526890975,0,0,4
55,Melanoma WP4685,0.15463406520469655,2.3364055299539173,4.361353770687086,"['GADD45A', 'BAX', 'CALM3', 'HRAS']",0.6757264526890975,0,0,4
56,Non-small cell lung cancer WP4255,0.15463406520469655,2.3364055299539173,4.361353770687086,"['GADD45A', 'CYCS', 'BAX', 'HRAS']",0.6757264526890975,0,0,4
57,Target Of Rapamycin (TOR) Signaling WP1471,0.17644987892305877,4.082329317269076,7.081691842939912,"['IDI1', 'HMGCR']",0.6757264526890975,0,0,2
58,BDNF-TrkB Signaling WP3676,0.17644987892305877,4.082329317269076,7.081691842939912,"['TRPC3', 'HRAS']",0.6757264526890975,0,0,2
59,Tumor suppressor activity of SMARCB1 WP4204,0.17644987892305877,4.082329317269076,7.081691842939912,"['H3F3B', 'H3F3A']",0.6757264526890975,0,0,2
60,GABA receptor Signaling WP4159,0.17644987892305877,4.082329317269076,7.081691842939912,"['SLC32A1', 'AP2M1']",0.6757264526890975,0,0,2
61,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.17644987892305877,4.082329317269076,7.081691842939912,"['BAX', 'FADD']",0.6757264526890975,0,0,2
62,Methionine De Novo and Salvage Pathway WP3580,0.17644987892305877,4.082329317269076,7.081691842939912,"['AHCY', 'ODC1']",0.6757264526890975,0,0,2
63,Nucleotide metabolism WP404,0.17644987892305877,4.082329317269076,7.081691842939912,"['NME2', 'OAZ1']",0.6757264526890975,0,0,2
64,Oxidative Stress WP408,0.17644987892305877,4.082329317269076,7.081691842939912,"['TXN2', 'SOD1']",0.6757264526890975,0,0,2
65,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.19676609703028367,2.4507042253521125,3.9842068589887285,"['LDHA', 'PKM', 'BAX']",0.6757264526890975,0,0,3
66,15q11.2 copy number variation syndrome WP4940,0.19723841092514718,inf,inf,['TUBGCP4'],0.6757264526890975,0,0,1
67,Serotonin and anxiety WP3947,0.19723841092514718,inf,inf,['CRH'],0.6757264526890975,0,0,1
68,Serotonin and anxiety-related events WP3944,0.19723841092514718,inf,inf,['CRH'],0.6757264526890975,0,0,1
69,Vitamin B12 Disorders WP4271,0.19723841092514718,inf,inf,['CUBN'],0.6757264526890975,0,0,1
70,Composition of Lipid Particles WP3601,0.19723841092514718,inf,inf,['LDLR'],0.6757264526890975,0,0,1
71,Energy Metabolism WP1541,0.19723841092514718,inf,inf,['UCP3'],0.6757264526890975,0,0,1
72,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.19723841092514718,inf,inf,['MAFF'],0.6757264526890975,0,0,1
73,Glycerophospholipid Biosynthetic Pathway WP2533,0.19723841092514718,inf,inf,['CDIPT'],0.6757264526890975,0,0,1
74,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.19723841092514718,inf,inf,['ELOB'],0.6757264526890975,0,0,1
75,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.19723841092514718,inf,inf,['HRAS'],0.6757264526890975,0,0,1
76,Mitochondrial CII Assembly WP4920,0.19723841092514718,inf,inf,['SDHAF1'],0.6757264526890975,0,0,1
77,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.19723841092514718,inf,inf,['LDHA'],0.6757264526890975,0,0,1
78,Alzheimer's disease WP2059,0.1977125546756989,2.0433467741935485,3.312144659854176,"['ATP5MD', 'CYCS', 'CALM3', 'FADD']",0.6757264526890975,0,0,4
79,Glycolysis and Gluconeogenesis WP534,0.1977125546756989,2.0433467741935485,3.312144659854176,"['LDHA', 'PKM', 'PGAM1', 'ALDOC']",0.6757264526890975,0,0,4
80,IL-18 signaling pathway WP4754,0.2131887931534181,1.4080393660531698,2.1762334747223995,"['ARL4D', 'IMP3', 'TMSB4X', 'RGS16', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'FADD', 'RND2', 'ITM2C']",0.7195121768927861,0,0,11
81,16p11.2 proximal deletion syndrome WP4949,0.24385873727432444,1.8154121863799284,2.561848256469347,"['TCP1', 'SEZ6L2', 'CCT7', 'CDIPT']",0.8128624575810816,0,0,4
82,Amino Acid metabolism WP3925,0.2543117377512135,2.041247484909457,2.794864728468958,"['LDHA', 'PKM', 'ODC1']",0.8163181595737479,0,0,3
83,Metabolic reprogramming in colon cancer WP4290,0.2543117377512135,2.041247484909457,2.794864728468958,"['LDHA', 'PKM', 'PGAM1']",0.8163181595737479,0,0,3
84,Apoptosis Modulation by HSP70 WP384,0.2569890502361799,2.7202141900937082,3.6960143236860965,"['CYCS', 'FADD']",0.8163181595737479,0,0,2
85,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.2569890502361799,2.7202141900937082,3.6960143236860965,"['BANF1', 'HRAS']",0.8163181595737479,0,0,2
86,Exercise-induced Circadian Regulation WP410,0.29205058112151744,1.6330645161290323,2.0100219710565144,"['DNAJA1', 'IDI1', 'GSTP1', 'UCP3']",0.8405598567009326,0,0,4
87,Hepatitis B infection WP4666,0.29205058112151744,1.6330645161290323,2.0100219710565144,"['CYCS', 'BAX', 'FADD', 'HRAS']",0.8405598567009326,0,0,4
88,Unfolded protein response WP4925,0.3378465672910523,2.039156626506024,2.212818198083029,"['XBP1', 'DDIT3']",0.8405598567009326,0,0,2
89,Cori Cycle WP1946,0.3378465672910523,2.039156626506024,2.212818198083029,"['LDHA', 'PGAM1']",0.8405598567009326,0,0,2
90,MET in type 1 papillary renal cell carcinoma WP4205,0.3378465672910523,2.039156626506024,2.212818198083029,"['RPL11', 'HRAS']",0.8405598567009326,0,0,2
91,One-carbon metabolism and related pathways WP3940,0.3378465672910523,2.039156626506024,2.212818198083029,"['GPX4', 'SOD1']",0.8405598567009326,0,0,2
92,p53 transcriptional gene network WP4963,0.3378465672910523,2.039156626506024,2.212818198083029,"['GADD45A', 'BAX']",0.8405598567009326,0,0,2
93,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.35563631845707777,4.076152304609218,4.214116395486811,['HRAS'],0.8405598567009326,0,0,1
94,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.35563631845707777,4.076152304609218,4.214116395486811,['HRAS'],0.8405598567009326,0,0,1
95,Autophagy WP4923,0.35563631845707777,4.076152304609218,4.214116395486811,['MAP1LC3B'],0.8405598567009326,0,0,1
96,Trans-sulfuration and one-carbon metabolism WP2525,0.35563631845707777,4.076152304609218,4.214116395486811,['AHCY'],0.8405598567009326,0,0,1
97,Transcriptional cascade regulating adipogenesis WP4211,0.35563631845707777,4.076152304609218,4.214116395486811,['DDIT3'],0.8405598567009326,0,0,1
98,Dopamine metabolism WP2436,0.35563631845707777,4.076152304609218,4.214116395486811,['SOD1'],0.8405598567009326,0,0,1
99,Ebstein-Barr virus LMP1 signaling WP262,0.35563631845707777,4.076152304609218,4.214116395486811,['TRADD'],0.8405598567009326,0,0,1
100,Glycerolipids and Glycerophospholipids WP4722,0.35563631845707777,4.076152304609218,4.214116395486811,['CDIPT'],0.8405598567009326,0,0,1
101,IL-2 signaling pathway WP49,0.35563631845707777,4.076152304609218,4.214116395486811,['HRAS'],0.8405598567009326,0,0,1
102,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.35563631845707777,4.076152304609218,4.214116395486811,['BAX'],0.8405598567009326,0,0,1
103,MAPK Cascade WP422,0.35563631845707777,4.076152304609218,4.214116395486811,['HRAS'],0.8405598567009326,0,0,1
104,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.35563631845707777,4.076152304609218,4.214116395486811,['AHCY'],0.8405598567009326,0,0,1
105,miRNA regulation of p53 pathway in prostate cancer WP3982,0.35563631845707777,4.076152304609218,4.214116395486811,['BAX'],0.8405598567009326,0,0,1
106,MTHFR deficiency WP4288,0.35563631845707777,4.076152304609218,4.214116395486811,['CYCS'],0.8405598567009326,0,0,1
107,Nanoparticle-mediated activation of receptor signaling WP2643,0.35563631845707777,4.076152304609218,4.214116395486811,['HRAS'],0.8405598567009326,0,0,1
108,Overview of nanoparticle effects WP3287,0.35563631845707777,4.076152304609218,4.214116395486811,['BAX'],0.8405598567009326,0,0,1
109,PDGF Pathway WP2526,0.35563631845707777,4.076152304609218,4.214116395486811,['HRAS'],0.8405598567009326,0,0,1
110,PDGFR-beta pathway WP3972,0.35563631845707777,4.076152304609218,4.214116395486811,['HRAS'],0.8405598567009326,0,0,1
111,Peroxiredoxin 2 induced ovarian failure WP4873,0.35563631845707777,4.076152304609218,4.214116395486811,['BAX'],0.8405598567009326,0,0,1
112,PKC-gamma calcium signaling pathway in ataxia WP4760,0.35563631845707777,4.076152304609218,4.214116395486811,['TRPC3'],0.8405598567009326,0,0,1
113,RalA downstream regulated genes WP2290,0.35563631845707777,4.076152304609218,4.214116395486811,['HRAS'],0.8405598567009326,0,0,1
114,"Relationship between inflammation, COX-2 and EGFR WP4483",0.35563631845707777,4.076152304609218,4.214116395486811,['HRAS'],0.8405598567009326,0,0,1
115,Acute viral myocarditis WP4298,0.3734070846455836,1.529426559356137,1.5066168059184986,"['ENDOG', 'CYCS', 'BAX']",0.8405598567009326,0,0,3
116,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3734070846455836,1.529426559356137,1.5066168059184986,"['GADD45A', 'CYCS', 'BAX']",0.8405598567009326,0,0,3
117,Endometrial cancer WP4155,0.3734070846455836,1.529426559356137,1.5066168059184986,"['GADD45A', 'BAX', 'HRAS']",0.8405598567009326,0,0,3
118,Sleep regulation WP3591,0.41576904430508144,1.6305220883534137,1.4309875263825487,"['AHCY', 'CRH']",0.8405598567009326,0,0,2
119,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.41576904430508144,1.6305220883534137,1.4309875263825487,"['HRAS', 'MYL12B']",0.8405598567009326,0,0,2
120,Computational Model of Aerobic Glycolysis WP4629,0.41576904430508144,1.6305220883534137,1.4309875263825487,"['LDHA', 'PKM']",0.8405598567009326,0,0,2
121,DNA IR-double strand breaks and cellular response via ATM WP3959,0.41576904430508144,1.6305220883534137,1.4309875263825487,"['KAT5', 'BAX']",0.8405598567009326,0,0,2
122,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.41576904430508144,1.6305220883534137,1.4309875263825487,"['CD63', 'SOD1']",0.8405598567009326,0,0,2
123,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.41576904430508144,1.6305220883534137,1.4309875263825487,"['IFI27L2', 'HRAS']",0.8405598567009326,0,0,2
124,DNA damage response (only ATM dependent) WP710,0.43197190667655233,1.3588195841716968,1.1405859894057127,"['BAX', 'HRAS', 'LDLR']",0.8405598567009326,0,0,3
125,DNA damage response WP707,0.43197190667655233,1.3588195841716968,1.1405859894057127,"['GADD45A', 'CYCS', 'BAX']",0.8405598567009326,0,0,3
126,miRNA regulation of DNA damage response WP1530,0.43197190667655233,1.3588195841716968,1.1405859894057127,"['GADD45A', 'CYCS', 'BAX']",0.8405598567009326,0,0,3
127,Pathways in clear cell renal cell carcinoma WP4018,0.43197190667655233,1.3588195841716968,1.1405859894057127,"['LDHA', 'PKM', 'ALDOC']",0.8405598567009326,0,0,3
128,Senescence and Autophagy in Cancer WP615,0.4441302366264289,1.1990493166963756,0.9731933104346184,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'HRAS', 'GABARAP']",0.8405598567009326,0,0,5
129,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4828299080985106,2.0370741482965933,1.4831750369370766,['HRAS'],0.8405598567009326,0,0,1
130,Urea cycle and metabolism of amino groups WP497,0.4828299080985106,2.0370741482965933,1.4831750369370766,['ODC1'],0.8405598567009326,0,0,1
131,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.4828299080985106,2.0370741482965933,1.4831750369370766,['VIP'],0.8405598567009326,0,0,1
132,Cysteine and methionine catabolism WP4504,0.4828299080985106,2.0370741482965933,1.4831750369370766,['AHCY'],0.8405598567009326,0,0,1
133,Dual hijack model of Vif in HIV infection WP3300,0.4828299080985106,2.0370741482965933,1.4831750369370766,['ELOB'],0.8405598567009326,0,0,1
134,Fatty acid transporters WP5061,0.4828299080985106,2.0370741482965933,1.4831750369370766,['FABP6'],0.8405598567009326,0,0,1
135,Gastric acid production WP2596,0.4828299080985106,2.0370741482965933,1.4831750369370766,['VIP'],0.8405598567009326,0,0,1
136,Gastric Cancer Network 1 WP2361,0.4828299080985106,2.0370741482965933,1.4831750369370766,['H3F3A'],0.8405598567009326,0,0,1
137,Genes targeted by miRNAs in adipocytes WP1992,0.4828299080985106,2.0370741482965933,1.4831750369370766,['TMSB4X'],0.8405598567009326,0,0,1
138,Glutathione metabolism WP100,0.4828299080985106,2.0370741482965933,1.4831750369370766,['GPX4'],0.8405598567009326,0,0,1
139,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.4828299080985106,2.0370741482965933,1.4831750369370766,['LDHA'],0.8405598567009326,0,0,1
140,HIF1A and PPARG regulation of glycolysis WP2456,0.4828299080985106,2.0370741482965933,1.4831750369370766,['LDHA'],0.8405598567009326,0,0,1
141,IL-1 signaling pathway WP195,0.4828299080985106,2.0370741482965933,1.4831750369370766,['HSPB2'],0.8405598567009326,0,0,1
142,Interleukin-11 Signaling Pathway WP2332,0.4828299080985106,2.0370741482965933,1.4831750369370766,['HRAS'],0.8405598567009326,0,0,1
143,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.4828299080985106,2.0370741482965933,1.4831750369370766,['HRAS'],0.8405598567009326,0,0,1
144,Kit receptor signaling pathway WP304,0.4828299080985106,2.0370741482965933,1.4831750369370766,['HRAS'],0.8405598567009326,0,0,1
145,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.4828299080985106,2.0370741482965933,1.4831750369370766,['LDLR'],0.8405598567009326,0,0,1
146,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.4828299080985106,2.0370741482965933,1.4831750369370766,['EIF3I'],0.8405598567009326,0,0,1
147,One-carbon metabolism WP241,0.4828299080985106,2.0370741482965933,1.4831750369370766,['AHCY'],0.8405598567009326,0,0,1
148,Osteoclast Signaling WP12,0.4828299080985106,2.0370741482965933,1.4831750369370766,['ATP6V1G1'],0.8405598567009326,0,0,1
149,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.4828299080985106,2.0370741482965933,1.4831750369370766,['HRAS'],0.8405598567009326,0,0,1
150,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.4828299080985106,2.0370741482965933,1.4831750369370766,['BAX'],0.8405598567009326,0,0,1
151,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.4828299080985106,2.0370741482965933,1.4831750369370766,['CALM3'],0.8405598567009326,0,0,1
152,AGE/RAGE pathway WP2324,0.48876999074832006,1.35809906291834,0.9722132317266254,"['CYCS', 'SOD1']",0.8405598567009326,0,0,2
153,Base Excision Repair WP4752,0.48876999074832006,1.35809906291834,0.9722132317266254,"['NEIL2', 'POLE3']",0.8405598567009326,0,0,2
154,Ferroptosis WP4313,0.48876999074832006,1.35809906291834,0.9722132317266254,"['MAP1LC3B', 'GPX4']",0.8405598567009326,0,0,2
155,Modulators of TCR signaling and T cell activation WP5072,0.48876999074832006,1.35809906291834,0.9722132317266254,"['NDUFB10', 'ELOB']",0.8405598567009326,0,0,2
156,Oncostatin M Signaling Pathway WP2374,0.48876999074832006,1.35809906291834,0.9722132317266254,"['HRAS', 'LDLR']",0.8405598567009326,0,0,2
157,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.48876999074832006,1.35809906291834,0.9722132317266254,"['BAX', 'HRAS']",0.8405598567009326,0,0,2
158,DNA Repair Pathways Full Network WP4946,0.541957231963657,1.1106639839034205,0.6803574246208212,"['NEIL2', 'CENPX', 'POLE3']",0.8923065328047532,0,0,3
159,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5557580207380974,1.1635111876075732,0.6834724108780297,"['BAX', 'HRAS']",0.8923065328047532,0,0,2
160,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5557580207380974,1.1635111876075732,0.6834724108780297,"['CYCS', 'FADD']",0.8923065328047532,0,0,2
161,Head and Neck Squamous Cell Carcinoma WP4674,0.5557580207380974,1.1635111876075732,0.6834724108780297,"['FADD', 'HRAS']",0.8923065328047532,0,0,2
162,Myometrial relaxation and contraction pathways WP289,0.5664239991292054,1.0176767676767677,0.5784600594974784,"['RGS16', 'MAFF', 'CRH', 'CALM3', 'IGFBP6']",0.8923065328047532,0,0,5
163,Bile acids synthesis and enterohepatic circulation  WP4389,0.5849565048386716,1.357381429525718,0.7278520638357214,['LDLR'],0.8923065328047532,0,0,1
164,Trans-sulfuration pathway WP2333,0.5849565048386716,1.357381429525718,0.7278520638357214,['AHCY'],0.8923065328047532,0,0,1
165,Type 2 papillary renal cell carcinoma WP4241,0.5849565048386716,1.357381429525718,0.7278520638357214,['ELOB'],0.8923065328047532,0,0,1
166,White fat cell differentiation WP4149,0.5849565048386716,1.357381429525718,0.7278520638357214,['DDIT3'],0.8923065328047532,0,0,1
167,ERK Pathway in Huntington's Disease WP3853,0.5849565048386716,1.357381429525718,0.7278520638357214,['HRAS'],0.8923065328047532,0,0,1
168,Ethanol effects on histone modifications WP3996,0.5849565048386716,1.357381429525718,0.7278520638357214,['AHCY'],0.8923065328047532,0,0,1
169,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5849565048386716,1.357381429525718,0.7278520638357214,['HRAS'],0.8923065328047532,0,0,1
170,Glycosylation and related congenital defects WP4521,0.5849565048386716,1.357381429525718,0.7278520638357214,['DPM3'],0.8923065328047532,0,0,1
171,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5849565048386716,1.357381429525718,0.7278520638357214,['VEGFB'],0.8923065328047532,0,0,1
172,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5849565048386716,1.357381429525718,0.7278520638357214,['SCO2'],0.8923065328047532,0,0,1
173,Neovascularisation processes WP4331,0.5849565048386716,1.357381429525718,0.7278520638357214,['CXCL12'],0.8923065328047532,0,0,1
174,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.5849565048386716,1.357381429525718,0.7278520638357214,['GSTP1'],0.8923065328047532,0,0,1
175,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5849565048386716,1.357381429525718,0.7278520638357214,['BAX'],0.8923065328047532,0,0,1
176,Regulation of Microtubule Cytoskeleton WP2038,0.5849565048386716,1.357381429525718,0.7278520638357214,['CFL2'],0.8923065328047532,0,0,1
177,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5849565048386716,1.357381429525718,0.7278520638357214,['ANAPC11'],0.8923065328047532,0,0,1
178,EGF/EGFR signaling pathway WP437,0.5921169688220596,1.017605633802817,0.5332773325738958,"['NDUFA13', 'HRAS', 'AP2M1']",0.8931373272734977,0,0,3
179,Insulin Signaling WP481,0.5921169688220596,1.017605633802817,0.5332773325738958,"['XBP1', 'HRAS', 'VAMP2']",0.8931373272734977,0,0,3
180,22q11.2 copy number variation syndrome WP4657,0.6162620473668624,1.017570281124498,0.4925884788104164,"['RANBP1', 'MRPL40']",0.9003086416466074,0,0,2
181,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6162620473668624,1.017570281124498,0.4925884788104164,"['TMSB4X', 'SOD1']",0.9003086416466074,0,0,2
182,Chemokine signaling pathway WP3929,0.6162620473668624,1.017570281124498,0.4925884788104164,"['CXCL12', 'HRAS']",0.9003086416466074,0,0,2
183,7-oxo-C and 7beta-HC pathways WP5064,0.6669482889014148,1.0175350701402806,0.4121452172316706,['ACOT11'],0.9003086416466074,0,0,1
184,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6669482889014148,1.0175350701402806,0.4121452172316706,['HRAS'],0.9003086416466074,0,0,1
185,ATM Signaling Network in Development and Disease  WP3878,0.6669482889014148,1.0175350701402806,0.4121452172316706,['KAT5'],0.9003086416466074,0,0,1
186,ATM Signaling Pathway WP2516,0.6669482889014148,1.0175350701402806,0.4121452172316706,['GADD45A'],0.9003086416466074,0,0,1
187,CAMKK2  Pathway WP4874,0.6669482889014148,1.0175350701402806,0.4121452172316706,['FIS1'],0.9003086416466074,0,0,1
188,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6669482889014148,1.0175350701402806,0.4121452172316706,['FADD'],0.9003086416466074,0,0,1
189,Cardiac Progenitor Differentiation WP2406,0.6669482889014148,1.0175350701402806,0.4121452172316706,['MESP1'],0.9003086416466074,0,0,1
190,DNA Mismatch Repair WP531,0.6669482889014148,1.0175350701402806,0.4121452172316706,['POLE3'],0.9003086416466074,0,0,1
191,Heart Development WP1591,0.6669482889014148,1.0175350701402806,0.4121452172316706,['VEGFB'],0.9003086416466074,0,0,1
192,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6669482889014148,1.0175350701402806,0.4121452172316706,['DDIT3'],0.9003086416466074,0,0,1
193,IL-6 signaling pathway WP364,0.6669482889014148,1.0175350701402806,0.4121452172316706,['VIP'],0.9003086416466074,0,0,1
194,Imatinib and Chronic Myeloid Leukemia WP3640,0.6669482889014148,1.0175350701402806,0.4121452172316706,['GADD45A'],0.9003086416466074,0,0,1
195,Integrin-mediated Cell Adhesion WP185,0.6669482889014148,1.0175350701402806,0.4121452172316706,['HRAS'],0.9003086416466074,0,0,1
196,Joubert Syndrome WP4656,0.6669482889014148,1.0175350701402806,0.4121452172316706,['KAT5'],0.9003086416466074,0,0,1
197,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6669482889014148,1.0175350701402806,0.4121452172316706,['CYCS'],0.9003086416466074,0,0,1
198,Pre-implantation embryo WP3527,0.6669482889014148,1.0175350701402806,0.4121452172316706,['DDIT3'],0.9003086416466074,0,0,1
199,Ebola Virus Pathway on Host WP4217,0.670229766559141,0.9040606871932173,0.36174604301289676,"['HLA-B', 'CLEC4G']",0.9003086416466074,0,0,2
200,Endoderm differentiation WP2853,0.670229766559141,0.9040606871932173,0.36174604301289676,"['TCEAL2', 'NME1']",0.9003086416466074,0,0,2
201,Oxidative Damage WP3941,0.670229766559141,0.9040606871932173,0.36174604301289676,"['GADD45A', 'CYCS']",0.9003086416466074,0,0,2
202,Small cell lung cancer WP4658,0.6812019582916313,0.8713710836447255,0.3345162703756006,"['GADD45A', 'CYCS', 'BAX']",0.9015908271506885,0,0,3
203,Complement system WP2806,0.6812019582916313,0.8713710836447255,0.3345162703756006,"['RPS19', 'CD59', 'CALR']",0.9015908271506885,0,0,3
204,Proximal tubule transport WP4917,0.6812019582916313,0.8713710836447255,0.3345162703756006,"['ATP6V1G1', 'SLC13A3', 'ATP6V1F']",0.9015908271506885,0,0,3
205,Gastrin signaling pathway WP4659,0.7178812856432351,0.8132530120481928,0.2695535760908127,"['KAT5', 'HRAS']",0.9075573822359378,0,0,2
206,Pancreatic adenocarcinoma pathway WP4263,0.7178812856432351,0.8132530120481928,0.2695535760908127,"['GADD45A', 'BAX']",0.9075573822359378,0,0,2
207,Regulation of Actin Cytoskeleton WP51,0.7178812856432351,0.8132530120481928,0.2695535760908127,"['CFL2', 'TMSB4X']",0.9075573822359378,0,0,2
208,Adipogenesis WP236,0.719973358400836,0.8128772635814889,0.26706356585631646,"['GADD45A', 'DDIT3', 'MIF']",0.9075573822359378,0,0,3
209,Circadian rhythm related genes WP3594,0.7263884552606122,0.8125,0.2597321552391428,"['AHCY', 'CRH', 'RPS27A', 'UBA52']",0.9075573822359378,0,0,4
210,Alpha 6 Beta 4 signaling pathway WP244,0.7327685530645721,0.8136272545090181,0.25297736323567127,['HRAS'],0.9075573822359378,0,0,1
211,Aryl Hydrocarbon Receptor Netpath WP2586,0.7327685530645721,0.8136272545090181,0.25297736323567127,['HRAS'],0.9075573822359378,0,0,1
212,Toll-like Receptor Signaling Pathway WP75,0.7327685530645721,0.8136272545090181,0.25297736323567127,['FADD'],0.9075573822359378,0,0,1
213,Genes controlling nephrogenesis WP4823,0.7327685530645721,0.8136272545090181,0.25297736323567127,['CXCL12'],0.9075573822359378,0,0,1
214,Integrated Cancer Pathway WP1971,0.7327685530645721,0.8136272545090181,0.25297736323567127,['BAX'],0.9075573822359378,0,0,1
215,Nucleotide Excision Repair WP4753,0.7327685530645721,0.8136272545090181,0.25297736323567127,['POLE3'],0.9075573822359378,0,0,1
216,Oxysterols derived from cholesterol WP4545,0.7327685530645721,0.8136272545090181,0.25297736323567127,['ACOT11'],0.9075573822359378,0,0,1
217,Pathways affected in adenoid cystic carcinoma WP3651,0.7327685530645721,0.8136272545090181,0.25297736323567127,['HRAS'],0.9075573822359378,0,0,1
218,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7327685530645721,0.8136272545090181,0.25297736323567127,['BAX'],0.9075573822359378,0,0,1
219,Aryl Hydrocarbon Receptor Pathway WP2873,0.7856017238466879,0.677688710754843,0.16352989638555784,['BAX'],0.9182357811195053,0,0,1
220,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7856017238466879,0.677688710754843,0.16352989638555784,['HRAS'],0.9182357811195053,0,0,1
221,TGF-beta Receptor Signaling WP560,0.7856017238466879,0.677688710754843,0.16352989638555784,['HRAS'],0.9182357811195053,0,0,1
222,Thermogenesis WP4321,0.7856017238466879,0.677688710754843,0.16352989638555784,['HRAS'],0.9182357811195053,0,0,1
223,Type II interferon signaling (IFNG) WP619,0.7856017238466879,0.677688710754843,0.16352989638555784,['HLA-B'],0.9182357811195053,0,0,1
224,DNA Replication WP466,0.7856017238466879,0.677688710754843,0.16352989638555784,['UBA52'],0.9182357811195053,0,0,1
225,Fragile X Syndrome  WP4549,0.7856017238466879,0.677688710754843,0.16352989638555784,['AP2M1'],0.9182357811195053,0,0,1
226,G13 Signaling Pathway WP524,0.7856017238466879,0.677688710754843,0.16352989638555784,['CFL2'],0.9182357811195053,0,0,1
227,Galanin receptor pathway WP4970,0.7856017238466879,0.677688710754843,0.16352989638555784,['VAMP2'],0.9182357811195053,0,0,1
228,IL-3 signaling pathway WP286,0.7856017238466879,0.677688710754843,0.16352989638555784,['HRAS'],0.9182357811195053,0,0,1
229,Mesodermal commitment pathway WP2857,0.7856017238466879,0.677688710754843,0.16352989638555784,['RPL38'],0.9182357811195053,0,0,1
230,PPAR signaling pathway WP3942,0.7856017238466879,0.677688710754843,0.16352989638555784,['FABP6'],0.9182357811195053,0,0,1
231,Prolactin Signaling Pathway WP2037,0.7856017238466879,0.677688710754843,0.16352989638555784,['HRAS'],0.9182357811195053,0,0,1
232,Cell cycle WP179,0.8143636488798104,0.676391683433937,0.13889586179474647,"['GADD45A', 'CDC14A', 'ANAPC11']",0.9315069484858656,0,0,3
233,Bladder cancer WP2828,0.8280061764318805,0.5805897509304323,0.109577412240612,['HRAS'],0.9315069484858656,0,0,1
234,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8280061764318805,0.5805897509304323,0.109577412240612,['HRAS'],0.9315069484858656,0,0,1
235,Corticotropin-releasing hormone signaling pathway WP2355,0.8280061764318805,0.5805897509304323,0.109577412240612,['CRH'],0.9315069484858656,0,0,1
236,ESC Pluripotency Pathways WP3931,0.8280061764318805,0.5805897509304323,0.109577412240612,['HRAS'],0.9315069484858656,0,0,1
237,Glycogen Synthesis and Degradation WP500,0.8280061764318805,0.5805897509304323,0.109577412240612,['CALM3'],0.9315069484858656,0,0,1
238,Hippo-Merlin Signaling Dysregulation WP4541,0.8280061764318805,0.5805897509304323,0.109577412240612,['HRAS'],0.9315069484858656,0,0,1
239,Nephrotic syndrome WP4758,0.8280061764318805,0.5805897509304323,0.109577412240612,['CUBN'],0.9315069484858656,0,0,1
240,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8280061764318805,0.5805897509304323,0.109577412240612,['NDUFA13'],0.9315069484858656,0,0,1
241,NRF2 pathway WP2884,0.839184063950824,0.6404744255003706,0.11229131420904206,"['PRDX1', 'GSTP1', 'MAFF']",0.940164718949056,0,0,3
242,AMP-activated protein kinase (AMPK) signaling WP1403,0.8620371153978637,0.5077655310621243,0.07538132304131116,['HMGCR'],0.9450966252654752,0,0,1
243,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8620371153978637,0.5077655310621243,0.07538132304131116,['BEX3'],0.9450966252654752,0,0,1
244,ErbB signaling pathway WP673,0.8620371153978637,0.5077655310621243,0.07538132304131116,['HRAS'],0.9450966252654752,0,0,1
245,G Protein Signaling Pathways WP35,0.8620371153978637,0.5077655310621243,0.07538132304131116,['HRAS'],0.9450966252654752,0,0,1
246,G1 to S cell cycle control WP45,0.8620371153978637,0.5077655310621243,0.07538132304131116,['GADD45A'],0.9450966252654752,0,0,1
247,Allograft Rejection WP2328,0.8772390027850835,0.5408299866131191,0.07083564048922553,"['CXCL12', 'HLA-B']",0.9450966252654752,0,0,2
248,Breast cancer pathway WP4262,0.8803294455173318,0.5789019833285427,0.07378630937878344,"['GADD45A', 'BAX', 'HRAS']",0.9450966252654752,0,0,3
249,Calcium Regulation in the Cardiac Cell WP536,0.8803294455173318,0.5789019833285427,0.07378630937878344,"['RGS16', 'CALM3', 'CALR']",0.9450966252654752,0,0,3
250,T-cell receptor (TCR) signaling pathway WP69,0.889345376559647,0.45112447116455134,0.0529031947863593,['HRAS'],0.9450966252654752,0,0,1
251,Endochondral Ossification with Skeletal Dysplasias WP4808,0.889345376559647,0.45112447116455134,0.0529031947863593,['HMGCS1'],0.9450966252654752,0,0,1
252,Endochondral Ossification WP474,0.889345376559647,0.45112447116455134,0.0529031947863593,['HMGCS1'],0.9450966252654752,0,0,1
253,Regulation of toll-like receptor signaling pathway WP1449,0.889345376559647,0.45112447116455134,0.0529031947863593,['FADD'],0.9450966252654752,0,0,1
254,Retinoblastoma gene in cancer WP2446,0.889345376559647,0.45112447116455134,0.0529031947863593,['H2AFZ'],0.9450966252654752,0,0,1
255,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8968971512369392,0.5067771084337349,0.055144485881416294,"['PSMD8', 'STUB1']",0.9450966252654752,0,0,2
256,Ras signaling WP4223,0.8968971512369392,0.5067771084337349,0.055144485881416294,"['CALM3', 'HRAS']",0.9450966252654752,0,0,2
257,Wnt signaling pathway and pluripotency WP399,0.9112568591791792,0.405811623246493,0.03771226425791359,['LDLR'],0.9450966252654752,0,0,1
258,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9112568591791792,0.405811623246493,0.03771226425791359,['HRAS'],0.9450966252654752,0,0,1
259,Glioblastoma signaling pathways WP2261,0.9112568591791792,0.405811623246493,0.03771226425791359,['HRAS'],0.9450966252654752,0,0,1
260,Focal Adhesion WP306,0.9118437469972303,0.5280377919692065,0.048730830252036554,"['VEGFB', 'HRAS', 'MYL12B']",0.9450966252654752,0,0,3
261,Metapathway biotransformation Phase I and II WP702,0.9135934044232926,0.4767304512166312,0.04308196851777276,"['GPX4', 'GSTP1']",0.9450966252654752,0,0,2
262,Spinal Cord Injury WP2431,0.9277288769214609,0.4500223114680946,0.03375876002901047,"['GADD45A', 'MIF']",0.9535582609221064,0,0,2
263,B Cell Receptor Signaling Pathway WP23,0.9288363800833852,0.3687374749498998,0.02722118878529649,['HRAS'],0.9535582609221064,0,0,1
264,MAPK Signaling Pathway WP382,0.9451702702008455,0.46641386782231853,0.026301165511416206,"['GADD45A', 'DDIT3', 'HRAS']",0.9666514127054102,0,0,3
265,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9706009221759153,0.269873079492318,0.00805298351940482,['HRAS'],0.9889141471226307,0,0,1
266,Vitamin D Receptor Pathway WP2877,0.9760840726469064,0.33651271753681394,0.008145814033233131,"['GADD45A', 'ZNF257']",0.9907620286265593,0,0,2
267,Nuclear Receptors Meta-Pathway WP2882,0.9883161795502552,0.3826804915514593,0.004497495582843641,"['PRDX1', 'GSTP1', 'MAFF', 'BAX']",0.9987229422978386,0,0,4
268,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9957898244461948,0.24364123159303883,0.001027937778008107,"['VEGFB', 'HRAS']",0.9987229422978386,0,0,2
269,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9959988423092533,0.1679191716766867,0.0006732188124385852,['VAMP2'],0.9987229422978386,0,0,1
270,PI3K-Akt signaling pathway WP4172,0.9987229422978386,0.205540109154567,0.0002626543275841555,"['VEGFB', 'HRAS']",0.9987229422978386,0,0,2
